Evaluation of the HPV ISH Assay in Cervical Cancer
ÀÌÁ¤ÀÇ, ½ÅÁ¤ÇÏ, ±èÁ¾¿Á, ÃÖ¿µÁø, À̱³¿µ, ¹ÚÁ¾¼·, ÀÌ¿øö, À̾ƿø,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¤ÀÇ ( Lee Jung-Uee )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
½ÅÁ¤ÇÏ ( Shin Jung-Ha )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
±èÁ¾¿Á ( Kim Jong-Ok )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÃÖ¿µÁø ( Choi Yeong-Jin )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
À̱³¿µ ( Lee Kyo-Young )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
¹ÚÁ¾¼· ( Park Jong-Sup )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰúÇб³½Ç
ÀÌ¿øö ( Lee Won-Chul )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç
À̾ƿø ( Lee Ah-Won )
°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ º´¿øº´¸®Çб³½Ç
KMID : 0357920100440050513
Abstract
Background : Human papillomavirus (HPV) infection can be detected by in situ hybridization (ISH), in which a punctate signal pattern indicates integrated HPV DNA and a diffuse pattern denotes the presence of episomal viral DNA. This study was conducted to evaluate the usefulness of an HPV ISH assay for invasive cervical cancer.
Methods : The HPV ISH assay for high-risk HPV and immunohistochemical staining for p16INK4a, p53, bcl-2, and Ki-67 were performed in a tissue microarray of 279 cervical cancers.
Results : High-risk HPV ISH was positive in 194 (69.5%) of the samples. Punctate, diffuse, and mixed signal patterns were observed in 157 (56.3%), one (0.4%), and 36 cases (12.9%), respectively. Positive results in high-risk HPV ISH were associated with p16 and bcl-2 expression (p = 0.01 and p < 0.01, respectively). According to a Cox regression analysis, HPV infection and its surrogate immunohistochemical markers such as p16, bcl-2, and Ki-67 were not independent prognostic factors, but stage and grade were independent prognostic factors.
Conclusions : Our results confirm that an HPV ISH assay is reasonably sensitive for HPV infection and that it might be useful to identify integrated HPV DNA in formalin-fixed and paraffin-embedded specimens. Further study encompassing HPV type, E2/E6 ratio, and therapeutic modality is necessary to understand the clinical meaning of HPV status in cervical cancer.
Å°¿öµå
HPV; In situ hybridization; Cervical cancer
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸